RZLT
Companies
NASDAQ
Rezolute, Inc.
Health Care
$4.07
-$0.83 (-16.94%)
Price Chart
Overview
About RZLT
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
Market Cap
$229.6M
Volume
3.5M
Avg. Volume
2.7M
P/E Ratio
-1.9692308
Dividend Yield
0.00%
Employees
54.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.40
Low Correlation
Volatility
High (0.74)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, RZLT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025